A Novel Intervention for Weight Loss in Young Adults

NCT ID: NCT06230744

Last Updated: 2025-11-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

140 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-10

Study Completion Date

2028-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Obesity and cardiometabolic risks are significant public health issues, with about two-thirds of U.S. adults overweight or obese. Weight loss can prevent these health problems, but current lifestyle interventions have limited success. New, effective strategies are needed to address this rising issue at the population level. The goal of this clinical trial is to investigate how a behavioral intervention combined with technology impacts weight loss in young adults. The main questions it aims to answer are:

• How does the combination of behavioral intervention and technology influence weight loss in young adults?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study team is seeking volunteers to participate in a research study to help better understand how a behavioral intervention combined with technology may impact weight loss. Participation will span approximately 6 months. Participants will be required to attend up to 5 visits at the University of Chicago. Those visits will include daytime visits to a clinic involving fasted blood draws and completion of surveys. During the study, participants will regularly record their weight using a digital scale, input their daily food intake into a smartphone app, and wear a wrist activity monitor to track their physical activity. Participants will also be paired with a trained coach to guide and assist their progress over their 6 months of participation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Weight Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lifestyle Intervention

Diet and exercise coaching

Group Type OTHER

Lifestyle

Intervention Type BEHAVIORAL

All participants will receive diet and exercise goals and coaching.

Lifestyle Intervention II

Diet and exercise coaching

Group Type EXPERIMENTAL

Lifestyle II

Intervention Type BEHAVIORAL

All participants will receive diet and exercise goals and coaching.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lifestyle

All participants will receive diet and exercise goals and coaching.

Intervention Type BEHAVIORAL

Lifestyle II

All participants will receive diet and exercise goals and coaching.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Overweight or obese (BMI 25.5- 34.9 kg/m2) men and women
* Ages 18 to 40 years
* Weight stable (no change \>25 lbs in the past 3 months)
* Owns a smartphone and willing to install the study app

Exclusion Criteria

* Presence of obstructive sleep apnea or history of any other sleep disorder.
* Irregular menses, menopausal symptoms or post-menopausal, currently pregnant, trying to get pregnant or nursing
* Regular travel across time zones
* Subjects who are currently following a weight loss regimen or any other special diet or exercise programs
* Increased fractional lean body mass (e.g., athletes)
* Unable to walk, using an assistive device for mobility, or any contraindications to exercise
* Diabetes
* Claustrophobia
* Excessive alcohol (\>2 drinks/day) or caffeine (\>300mg/day) intake, regular nicotine use, substance abuse.
* Abnormal findings on screening blood testing.
* Participants taking any prescription, over-the-counter drugs/supplements that can affect sleep or weight.
* Major psychiatric or any eating disorder, and any acute or chronic medical condition that increase the risk of interventions (e.g., heart disease)
* Any underlying disease likely to limit life span and/or increase risk of interventions including cardiovascular disease (e.g. unstable angina, heart failure requiring hospitalization in the past 6 months, significant heart block or arrhythmias, NYHA Class\>2), pulmonary disease with dependence on oxygen or daily use of bronchodilators, cancer requiring treatment in the past 5 years unless the prognosis is considered good, active or chronic infection, thyroid disease and other endocrine disorders (e.g. Cushing syndrome, acromegaly), hepatitis or other chronic gastrointestinal disease (pancreatitis, inflammatory bowel disease), renal disease, significant anemia, recent surgery or significant abdominal surgery, major psychiatric or any eating disorder, acute coronary syndrome or stroke in the past 6 months
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northwestern University

OTHER

Sponsor Role collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

Sponsor Role collaborator

University of Chicago

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Esra Tasali, MD

Role: PRINCIPAL_INVESTIGATOR

University of Chicago

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Chicago

Chicago, Illinois, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Olivia Hughes

Role: CONTACT

7737022348

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

UChicago IRB

Role: primary

773-702-6505

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01DK136214-01A1

Identifier Type: NIH

Identifier Source: secondary_id

View Link

IRB23-1677

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Weight Gain Prevention
NCT00606840 COMPLETED NA
Prevention of Weight Gain
NCT00011102 COMPLETED NA
Web-based Weight Loss Intervention
NCT03400696 COMPLETED NA